Delivery Order SPE2DR25D2102-SPE2DR26FB2NY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract valued at $49,344.60, with an ultimate completion date of January 5, 2026. This competitive award, issued on January 2, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $12,855.70 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages). This competitive, non-set-aside award is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a $59,781.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with an ultimate completion date of December 23, 2025. This competitively awarded contract, issued without a set-aside designation, represents a single delivery order under AmerisourceBergen's existing relationship with DLA for pharmaceutical procurement. The company will perform this work from its corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 count) under a firm fixed-price contract valued at $12,043.27. This non-competitive award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,057.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with a completion deadline of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp for $78,227.46 on January 22, 2026, for the supply of Arimidex 1 mg tablets (30-count). This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling...
- The Defense Logistics Agency awarded a $5,731.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside contract represents a routine pharmaceutical procurement fulfilling federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $4,894.46 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by January 5, 2026. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $17,825.92 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on January 23, 2026, with an ultimate completion date of January 26, 2026, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is...
- SPE2DR25D2102Indefinite Delivery Contract
- SPE2DR25D2102-SPE2DR26FB2NYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,852.78 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The company will perform the work at its corporate office location in Conshohocken, Pennsylvania, where it serves as a major pharmaceutical distributor and critical vendor for federal medical procurement needs. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a leading pharmaceutical distributor providing comprehensive medical supplies and medications to military and veteran healthcare systems. This delivery order is one of numerous task orders issued under the company's primary IDC with DLA Troop Support Medical, which enables the supply of brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities to support military healthcare programs globally. The contract demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements through open competition and firm fixed-price arrangements across a diverse range of pharmaceutical products and therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 1/22/26 |